Key result
In patients with transthyretin amyloidosis cardiomyopathy, the sensitivity of amyloid deposition was 38% in subcutaneous tissue, 61% in the gastrointestinal tract, and 99% in the endomyocardium, with a combined extracardiac biopsy sensitivity of 73%.
Why the study?
The accurate sensitivity of amyloid deposition in extracardiac tissue (subcutaneous tissue and gastrointestinal tract) had not been evaluated in ATTR-CM patients.
Does extracardiac biopsy have adequate sensitivity for detecting amyloid deposition in patients with ATTR-CM and positive 99mTc-PYP scintigraphy?
Observational (n=175)
No
Does extracardiac biopsy have adequate sensitivity for detecting amyloid deposition in patients with ATTR-CM and positive 99mTc-PYP scintigraphy?
Answers are grounded in this paper and cite their sources.
Shows lower extracardiac biopsy sensitivity in wild-type versus variant transthyretin amyloid cardiomyopathy, indicating limited diagnostic yield outside the heart.
BACKGROUND: The accurate sensitivity of amyloid deposition in extracardiac tissue (subcutaneous tissue and gastrointestinal tract) has not been evaluated in transthyretin amyloidosis cardiomyopathy (ATTR-CM) patients. This study aimed to evaluate the sensitivity of amyloid deposition in obtained endomyocardial and extracardiac biopsies. METHODS AND RESULTS: Tc-PYP) scintigraphy and underwent tissue biopsy of at least one organ (subcutaneous tissue, gastrointestinal tract, and endomyocardium). Amyloid deposition was observed in the subcutaneous tissue of 57/150 patients (38%), gastrointestinal tract of 80/131 patients (61%), and endomyocardium of 108/109 patients (99%). Compared to patients with ATTRv, ATTRwt had significantly lower sensitivity in subcutaneous tissue (73% vs. 25%, P<0.01) and tended to be lower in the gastrointestinal tract (74% vs. 57%, P=0.08) biopsies. Among 124 patients who underwent both subcutaneous tissue and gastrointestinal tract biopsies, amyloid was detected in at least 1 specimen in 91 (73%) patients. The sensitivity of the combination of extracardiac biopsies was 66% and 94% in ATTRwt-CM and ATTRv-CM, respectively. Multivariate analysis reveals that ATTRv was the only significant predictor of amyloid deposition in the subcutaneous tissue. CONCLUSIONS: Tc-PYP scintigraphy findings.
No takes yet. Share an insight, caveat, or question.
Nishi et al. (2022) conducted an observational in Transthyretin amyloidosis cardiomyopathy (ATTR-CM) (n=175). Extracardiac biopsy (subcutaneous tissue and gastrointestinal tract) vs. Endomyocardial biopsy was evaluated on Sensitivity of amyloid deposition in subcutaneous tissue biopsy. In patients with transthyretin amyloidosis cardiomyopathy, the sensitivity of amyloid deposition was 38% in subcutaneous tissue, 61% in the gastrointestinal tract, and 99% in the endomyocardium, with a combined extracardiac biopsy sensitivity of 73%.
Synapse has enriched 10 related papers. Consider them for comparative context: